• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by Auna SA

    9/12/24 9:47:04 PM ET
    $AUNA
    Medical/Nursing Services
    Health Care
    Get the next $AUNA alert in real time by email
    SC 13D/A 1 auna-sc13da_091224.htm AMENDMENT TO FORM SC-13D

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION 

    WASHINGTON, D.C. 20549

     

    SCHEDULE 13D

    (Amendment No. 1)*

     

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    Auna S.A.


    (Name of Issuer)

     

    Class A Ordinary Shares, nominal value US$0.01 per share 


    (Title of Class of Securities)

     

    L0415A 103 


    (CUSIP Number)

     

    José Luis Alberdi Gonzalez

    Camino a Santa Teresa 1055, piso 14,

    Héroes de Padierna, La Magdalena Contreras, Mexico, 10700

    (+ 52 (55) 5449-7488)

     

    With copies to:

     

    Cleary Gottlieb Steen & Hamilton LLP

    Attention: Manuel Silva

    One Liberty Plaza, New York NY 10006

    (212) 225-2000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    September 10, 2024


    (Date of Event Which Requires Filing of Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☒

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    CUSIP No. L0415A 103 Page 2 of 15

     

    (1)

    Name of Reporting Persons:

    Grupo Ángeles Servicios de Salud, S.A. de C.V.

    (2)

    Check the Appropriate Box if a Member of a Group (See Instructions):

    (a) ☐ (b) ☐

    (3) SEC Use Only:
    (4)

    Source of Funds (See Instructions):

    WC

    (5)

    Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e):

    ☐

    (6)

    Citizenship or Place of Organization:

    United Mexican States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    (7)

    Sole Voting Power

    0

    (8)

    Shared Voting Power

    6,660,000

    (9)

    Sole Dispositive Power

    0

    (10)

    Shared Dispositive Power

    6,660,000

    (11)

    Aggregate Amount Beneficially Owned by Each Reporting Person:

    6,660,000

    (12)

    Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):

    ☐

    (13)

    Percent of Class Represented by Amount in Row (11):

    22.20%(1)

    (14)

    Type of Reporting Person (See Instructions):

    OO

     

    (1) The calculation assumes that there is a total of 30,000,000 Class A Ordinary Shares (as defined below) outstanding as of March 21, 2024, as reported in the prospectus dated March 21, 2024 filed by the Issuer (as defined below) with the Securities and Exchange Commission (the “SEC”) on March 25, 2024 pursuant to Rule 424(b)(1) under the Securities Act of 1933, as amended (the “Final Prospectus”).

     

     

     

     

    CUSIP No. L0415A 103 Page 3 of 15

     

    (1)

    Name of Reporting Persons:

    Grupo Empresarial Ángeles, S.A. de C.V.

    (2)

    Check the Appropriate Box if a Member of a Group (See Instructions):

    (a) ☐ (b) ☐

    (3) SEC Use Only:
    (4)

    Source of Funds (See Instructions):

    WC

    (5)

    Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e):

    ☐

    (6)

    Citizenship or Place of Organization:

    United Mexican States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    (7)

    Sole Voting Power

    0

    (8)

    Shared Voting Power

    6,660,000

    (9)

    Sole Dispositive Power

    0

    (10)

    Shared Dispositive Power

    6,660,000

    (11)

    Aggregate Amount Beneficially Owned by Each Reporting Person:

    6,660,000

    (12)

    Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):

    ☐

    (13)

    Percent of Class Represented by Amount in Row (11):

    22.20%(2)

    (14)

    Type of Reporting Person (See Instructions):

    HC

     

    (2) The calculation assumes that there is a total of 30,000,000 Class A Ordinary Shares outstanding as of March 21, 2024, as reported in the Final Prospectus.

     

     

     

     

    CUSIP No. L0415A 103 Page 4 of 15

     

    (1)

    Name of Reporting Persons:

    Corpvaza, S.A. de C.V.

    (2)

    Check the Appropriate Box if a Member of a Group (See Instructions):

    (a) ☐ (b) ☐

    (3) SEC Use Only:
    (4)

    Source of Funds (See Instructions):

    WC

    (5)

    Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e):

    ☐

    (6)

    Citizenship or Place of Organization:

    United Mexican States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    (7)

    Sole Voting Power

    0

    (8)

    Shared Voting Power

    6,660,000

    (9)

    Sole Dispositive Power

    0

    (10)

    Shared Dispositive Power

    6,660,000

    (11)

    Aggregate Amount Beneficially Owned by Each Reporting Person:

    6,660,000

    (12)

    Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):

    ☐

    (13)

    Percent of Class Represented by Amount in Row (11):

    22.20%(3)

    (14)

    Type of Reporting Person (See Instructions):

    HC

     

    (3) The calculation assumes that there is a total of 30,000,000 Class A Ordinary Shares outstanding as of March 21, 2024, as reported in the Final Prospectus.

     

     

     

     

    CUSIP No. L0415A 103 Page 5 of 15

     

    (1)

    Name of Reporting Persons:

    Mr. Olegario Vázquez Aldir

    (2)

    Check the Appropriate Box if a Member of a Group (See Instructions):

    (a) ☐ (b) ☐

    (3) SEC Use Only:
    (4)

    Source of Funds (See Instructions):

    WC

    (5)

    Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e):

    ☐

    (6)

    Citizenship or Place of Organization:

    United Mexican States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    (7)

    Sole Voting Power

    6,660,000

    (8)

    Shared Voting Power

    0

    (9)

    Sole Dispositive Power

    6,660,000

    (10)

    Shared Dispositive Power

    0

    (11)

    Aggregate Amount Beneficially Owned by Each Reporting Person:

    6,660,000

    (12)

    Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):

    ☐

    (13)

    Percent of Class Represented by Amount in Row (11):

    22.20% (4)

    (14)

    Type of Reporting Person (See Instructions):

    IN

     

    (4) The calculation assumes that there is a total of 30,000,000 Class A Ordinary Shares outstanding as of March 21, 2024, as reported in the Final Prospectus.

     

     

     

     

    CUSIP No. L0415A 103 Page 6 of 15

     

    ITEM 1. SECURITY AND ISSUER

     

    Pursuant to Rule 13d-2 of the Securities Exchange Act of 1934, as amended, this Amendment No. 1 (this “Amendment”) amends and supplements the Schedule 13D originally filed by Grupo Ángeles Servicios de Salud, S.A. de C.V. (“GASS”), Grupo Empresarial Ángeles, S.A. de C.V. (“GEA”), Corpvaza, S.A. de. C.V. (“Corpvaza”), and Mr. Olegario Vásquez Aldir (“Mr. Vásquez Aldir,” and collectively with GASS, GEA, and Corpvaza, the “Reporting Persons”), on August 22, 2024 (the “Schedule 13D”) relating to the Class A Ordinary Shares, nominal value US$0.01 per share (the “Class A Ordinary Shares”), of Auna S.A., a public limited liability company incorporated in Grand Duchy of Luxembourg (“Auna”, or the “Issuer”). This Amendment amends the Schedule 13D on behalf of the Reporting Persons to furnish the information set forth herein, and except as set forth below, all Items of the Original Schedule 13D remain unchanged. Capitalized terms used in this Amendment and not otherwise defined shall have the same meanings ascribed to them in the Schedule 13D.

      

    ITEM 2. IDENTITY AND BACKGROUND

     

    This Amendment amends and supplements the following subsections of Item 2 of the Schedule 13D by inserting the below regarding the directors and executive officers of GASS (each a “Covered Person” and, collectively, the “Covered Persons”). Additionally, sections (d) and (e) of Item 2 of the Schedule 13D are amended and supplemented to refer to the Covered Persons. Any disclosures herein with respect to the Covered Persons and any additional persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

     

    (a), (b), (f) The name of each Covered Person, as well as his country of citizenship, present principal occupation, and the name, principal business, and address of the organization in which such occupation is conducted, is set forth on Schedule 1 hereto.

     

    ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

     

    This Amendment amends and restates Item 3 of the Schedule 13D as follows:

      

    From the date of its first acquisition of the Class A Ordinary Shares (as reported on the Schedule 13G filed on April 12, 2024 (SEC File No. 005-94489)) until September 12, 2024, GASS purchased 6,660,000 Class A Ordinary Shares for a total purchase price of USD$55,887,612 GASS used available cash on hand to acquire such Class A Ordinary Shares.

    ITEM 5. INTEREST IN SECURITIES OF THE ISSUER

     

    This Amendment amends and restates Item 5 of the Schedule 13D as follows:

     

    The information set forth in rows 7, 8, 9, 10, 11, and 13 on the respective cover pages of this Schedule 13D and the information set forth or incorporated in Items 2 and 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 5. 

     

    (a), (b) The following disclosure assumes there are 30,000,000 Class A Ordinary Shares outstanding as of March 21, 2024, as reported in the prospectus dated March 21, 2024 filed by the Issuer with the SEC on March 25, 2024 pursuant to the Final Prospectus. Pursuant to Rule 13d-3 under the Act, the Reporting Persons may be deemed to beneficially own 6,660,000 shares of Class A Ordinary Shares, which constitutes approximately 22.20% of the outstanding Class A Ordinary Shares.

     

    (c) All transactions in Class A Ordinary Shares effected by the Reporting Persons and, to the best knowledge of the Reporting Persons, the Covered Persons within the prior 60-day window for which disclosure is required by Schedule 13D are listed in Schedule 2 hereto and incorporated herein by reference.

     

    (d) To the best knowledge of the Reporting Persons, no person other than the Reporting Persons and their respective members, shareholders, and affiliates has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Persons identified in this Item 5.

     

    (e) Not applicable.

     

     

     

     

    CUSIP No. L0415A 103 Page 7 of 15

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this Schedule 13D is true, complete, and correct.

     

    Dated as of September 12, 2024

     

      Grupo Angeles Servicios de Salud, S.A. de C.V.
       
      /s/ Jose Luis Alberdi Gonzalez
      Name: Jose Luis Alberdi Gonzalez
      Title: Legal Vice President
       
       
      Grupo Empresarial Angeles, S.A. de C.V.
       
      /s/ Jose Luis Alberdi Gonzalez
      Name: Jose Luis Alberdi Gonzalez
      Title: Legal Vice President
       
      Corpvaza S.A. de C.V.
       
      /s/ Jose Luis Alberdi Gonzalez
      Name: Jose Luis Alberdi Gonzalez
      Title: Legal Vice President
       
       
      Olegario Vázquez Aldir
       
      /s/ Jose Luis Alberdi Gonzalez
      Name: Jose Luis Alberdi Gonzalez (5)
      Title: Authorized Signatory

     

    (5) Jose Luis Alberdi Gonzalez is signing on behalf of Mr. Vázquez Aldir pursuant to a power of attorney dated April 12, 2024, which was previously filed with the SEC as an exhibit to a Schedule 13G filed by Mr. Vázquez Aldir on April 12, 2024 (SEC File No. 005-94489). 

     

     

     

     

    CUSIP No. L0415A 103 Page 8 of 15

     

     

    Exhibit Index 

     

    1.Agreement of Joint Filing by Grupo Ángeles Servicios de Salud, S.A. de C.V., Grupo Empresarial Ángeles, S.A. de C.V., Corpvaza S.A. de C.V. and Olegario Vázquez Aldir dated as of August 22, 2024 (incorporated herein by reference to Exhibit 1 to Amendment No. 1 of the Schedule 13D filed by Grupo Ángeles Servicios de Salud, S.A. de C.V., Grupo Empresarial Ángeles, S.A. de C.V., Corpvaza S.A. de C.V. and Olegario Vázquez Aldir on August 22, 2024 with respect to the ordinary shares of Auna S.A.).

     

     

     
     

     

    CUSIP No. L0415A 103 Page 9 of 15

     

     

    Schedule 1

     

    Members of the Board of Directors of GASS

     

    Name Principal Business
    Address of Employer
    Present Principal Occupation or
    Employment
    Citizenship
    Jesús Ruíz López Grupo Ángeles Servicios de Salud, S.A. de C.V., Camino a Santa Teresa 1055, piso 14, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700 President of the Board of Directors GASS / Deputy Chief Executive Officer GASS United Mexican States
    Javier Santoveña Raña Grupo Ángeles Servicios de Salud, S.A. de C.V., Camino a Santa Teresa 1055, piso 14, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700 Member of the Board of Directors GASS United Mexican States
    Victor Manuel Ramírez González Grupo Ángeles Servicios de Salud, S.A. de C.V., Camino a Santa Teresa 1055, piso 14, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700 Member of the Board of Directors GASS United Mexican States

     

    Executive Officers and Directors of GASS

     

    Name Principal Business
    Address of Employer
    Present Principal Occupation or
    Employment
    Citizenship
    Olegario Vázquez Aldir Grupo Ángeles Servicios de Salud, S.A. de C.V., Camino a Santa Teresa 1055, piso 15, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700 Chief Executive Officer GASS United Mexican States
    Jesús Ruíz López   Grupo Ángeles Servicios de Salud, S.A. de C.V., Camino a Santa Teresa 1055, piso 15, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700 Deputy Chief Executive Officer GASS United Mexican States
    Carlos Alejandro De Luna Morales Grupo Ángeles Servicios de Salud, S.A. de C.V., Camino a Santa Teresa 1055, piso 15, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700 Vice President M&A United Mexican States
    Jorge Subirachs Cortés Grupo Ángeles Servicios de Salud, S.A. de C.V., Camino a Santa Teresa 1055, piso 14, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700 Chief Financial Officer GASS United Mexican States
    Víctor Manuel Ramírez González Grupo Ángeles Servicios de Salud, S.A. de C.V., Camino a Santa Teresa 1055, piso 14, Héroes de Padierna, La Magdalena Contreras, Mexico, 10700 Chief Operating Officer GASS United Mexican States

     

     
     

     

    CUSIP No. L0415A 103 Page 10 of 15

     

    Schedule 2

     

    The Reporting Persons effected the transactions in Class A Ordinary Shares on the New York Stock Exchange set forth below. The prices below reflect the price paid by the purchasers per Class A Ordinary Shares on the relevant trade date.

     

    Reporting Person Type of Transaction Trade Date Number of Shares Price per Share
    GASS Purchase 06/24/2024 66,114 $7.922 (1)
    GASS Purchase 06/25/2024 180,909 $7.840 (2)
    GASS Purchase 06/26/2024 113,910 $7.967 (3)
    GASS Purchase 06/27/2024 75,336 $8.004 (4)
    GASS Purchase 06/28/2024 90,464 $7.930 (5)
    GASS Purchase 07/02/2024 43,835 $7.956 (6)
    GASS Purchase 07/03/2024 10,000 $8.000 (7)
    GASS Purchase 07/05/2024 164,252 $7.968 (8)
    GASS Purchase 07/08/2024 52,739 $7.937 (9)
    GASS Purchase 07/09/2024 157,130 $7.871 (10)
    GASS Purchase 07/10/2024 114,829 $7.785 (11)
    GASS Purchase 07/11/2024 15,825 $7.783 (12)
    GASS Purchase 07/12/2024 16,221 $7.800 (13)
    GASS Purchase 07/15/2024 60,471 $7.941 (14)
    GASS Purchase 07/16/2024 57,345 $8.361 (15)
    GASS Purchase 07/17/2024 61,764 $8.775 (16)
    GASS Purchase 07/22/2024 31,913 $8.785 (17)
    GASS Purchase 07/23/2024 1,506 $8.550 (18)
    GASS Purchase 07/24/2024 13,257 $8.701 (19)
    GASS Purchase 07/25/2024 57,558 $8.933 (20)
    GASS Purchase 07/26/2024 99,394 $8.989 (21)
    GASS Purchase 07/29/2024 44,620 $8.997 (22)
    GASS Purchase 07/30/2024 49,127 $8.990 (23)
    GASS Purchase 07/31/2024 71,990 $8.820 (24)
    GASS Purchase 08/01/2024 10,000 $8.700 (25)
    GASS Purchase 08/02/2024 10,000 $8.596 (26)
    GASS Purchase 08/06/2024 25,000 $7.627 (27)
    GASS Purchase 08/07/2024 20,000 $7.588 (28)
    GASS Purchase 08/08/2024 38,320 $7.523 (29)
    GASS Purchase 08/09/2024 15,103 $7.426 (30)
    GASS Purchase 08/12/2024 15,185 $7.427 (31)
    GASS Purchase 08/14/2024 3,439 $7.445 (32)
    GASS Purchase 08/15/2024 2,874 $7.719 (33)
    GASS Purchase 08/16/2024 928 $7.760 (34)
    GASS Purchase 08/19/2024 26,904 $7.695 (35)
    GASS Purchase 08/20/2024 15,000 $7.602 (36)
    GASS Purchase 08/21/2024 10,000 $7.593 (37)
    GASS Purchase 08/22/2024 144,118 $7.304 (38)
    GASS Purchase 09/03/2024 98,881 $6.783 (39)
    GASS Purchase 09/04/2024 87,827 $6.893 (40)
    GASS Purchase 09/05/2024 22,092 $6.818 (41)
    GASS Purchase 09/06/2024 58,822 $6.785 (42)
    GASS Purchase 09/09/2024 27,076 $6.714 (43)
    GASS Purchase 09/10/2024 79,162 $6.766 (44)
    GASS Purchase 09/11/2024 121,969 $7.035 (45)
    GASS Purchase 09/12/2024 25,182 $7.549 (46)

     

     
     

     

    CUSIP No. L0415A 103 Page 11 of 15

     

    1.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.09 to $7.70 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1).

     

    2.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.02 to $7.21 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (2).

     

    3.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.98 to $7.95 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (3).

     

    4.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.05 to $7.95 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (4).

     

    5.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $7.80 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (5).

     

    6.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.99 to $7.85 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (6).

     

    7.Weighted average price. These shares were purchased in multiple transactions at a price of $8.00. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (7).

     

    8.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.00 to $7.80 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (8).

     

    9.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.95 to $7.85 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (9).

     

     
     

     

    CUSIP No. L0415A 103 Page 12 of 15

     

    10.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.94 to $7.75 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (10).

     

    11.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.85 to $7.70 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (11).

     

    12.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.80 to $7.75 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (12).

     

    13.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.80 to $7.80 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (13).

     

    14.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.06 to $7.75 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (14).

     

    15.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.44 to $8.26 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (15).

     

    16.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.96 to $8.57 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (16).

     

    17.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.80 to $8.76 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (17).

     

    18.Weighted average price. These shares were purchased in multiple transactions at a price of $8.55. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (18).

     

    19.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.74 to $8.65 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (19).

     

    20.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.00 to $8.80 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (20).

     

     
     

     

    CUSIP No. L0415A 103 Page 13 of 15

     

    21.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.00 to $8.80 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (21).

     

    22.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.00 to $9.00 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (22).

     

    23.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.99 to $8.90 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (23).

     

    24.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.90 to $8.80 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (24).

     

    25.Weighted average price. These shares were purchased in multiple transactions at a price of $8.70. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (25).

     

    26.Weighted average price. These shares were purchased in multiple transactions at a price of $8.60. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (26).

     

    27.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.70 to $7.57 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (27).

     

    28.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 to $7.51 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (28).

     

    29.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.56 to $7.48 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (29).

     

    30.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.46 to $7.38 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (30).

     

    31.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.44 to $7.38 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (31).

     

     

     
     

     

    CUSIP No. L0415A 103 Page 14 of 15

     

    32.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.50 to $7.39 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (32).

     

    33.Weighted average price. These shares were purchased in multiple transactions at a price of $7.72. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (33).

     

    34.Weighted average price. These shares were purchased in multiple transactions at a price of $7.76. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (34).

     

    35.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.80 to $7.55 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (35).

     

    36.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.61 to $7.59 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (36).

     

    37.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.60 to $7.59 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (37).

     

    38.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.49 to $7.25 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (38).

     

    39.6Weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.83 to $6.56 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (39).

     

    40.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.90 to $6.80 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (40).

     

    41.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.85 to $6.77 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (41).

     

    42.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.80 to $6.75 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (42).

     

     
     

     

    CUSIP No. L0415A 103 Page 15 of 15

     

    43.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.74 to $6.68 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (43).

     

    44.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.80 to $6.68 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (44).

     

    45.Weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.09 to $6.90 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (45).

     

    46.Weighted average price. These shares were purchased in multiple transactions at a price of $7.55. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (46).

     

     

     

    Get the next $AUNA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AUNA

    DatePrice TargetRatingAnalyst
    5/22/2025$7.90Buy → Hold
    HSBC Securities
    4/23/2024$12.60Buy
    HSBC Securities
    4/16/2024$16.00Overweight
    JP Morgan
    4/16/2024$14.00Overweight
    Morgan Stanley
    More analyst ratings

    $AUNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Auna SA

      SC 13G - AUNA S.A. (0001799207) (Subject)

      11/14/24 2:22:37 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Auna SA

      SC 13G/A - AUNA S.A. (0001799207) (Subject)

      11/13/24 10:53:24 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by Auna SA

      SC 13G - AUNA S.A. (0001799207) (Subject)

      11/12/24 6:09:04 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Auna Announces 1Q25 Financial Results

      Adjusted EBITDA increases 1% FXN YoY; Peru supports quarterly results, further validating its integrated business model Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the first quarter ended March 31, 2025 ("first quarter 2025" or "1Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 1Q25 Consolidated Highlights Consolidated Revenue decreased 3% YoY to S/1,042 million, increasing +4% FXN Adjusted EBITDA decreased 8% YoY to S/

      5/20/25 4:15:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal amount of its 10.000% senior secured notes (the "Additional Notes") in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. The Additional Notes will be an issuance of Auna's existing 10.000% senior secured notes due 2029 and will be issued a

      5/7/25 7:17:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces Proposed Offering of Additional 10.000% Senior Secured Notes Due 2029

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it intends to offer additional 10.000% senior secured notes (the "Additional Notes") in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. The Additional Notes will be an issuance of Auna's existing 10.000% senior secured notes due 2029 and will be issued as additional notes under the indenture dated as of December 18, 2023 (as amended a

      5/6/25 9:12:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Auna S.A. downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded Auna S.A. from Buy to Hold and set a new price target of $7.90

      5/22/25 10:32:04 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • HSBC Securities initiated coverage on Auna S.A. with a new price target

      HSBC Securities initiated coverage of Auna S.A. with a rating of Buy and set a new price target of $12.60

      4/23/24 6:12:32 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Morgan Stanley initiated coverage on Auna S.A. with a new price target

      Morgan Stanley initiated coverage of Auna S.A. with a rating of Overweight and set a new price target of $14.00

      4/16/24 7:35:01 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    SEC Filings

    See more
    • SEC Form 6-K filed by Auna SA

      6-K - AUNA S.A. (0001799207) (Filer)

      6/6/25 4:16:25 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • SEC Form 6-K filed by Auna SA

      6-K - AUNA S.A. (0001799207) (Filer)

      5/20/25 4:23:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • SEC Form EFFECT filed by Auna SA

      EFFECT - AUNA S.A. (0001799207) (Filer)

      5/8/25 12:15:17 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Leadership Updates

    Live Leadership Updates

    See more
    • Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico. As part of this agreement, eight highly regarded physicians – six oncologists and two radiation oncologists – will join Auna. Toda

      3/7/25 8:00:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna appoints Teresa Gutierrez and Guadalupe Phillips to Its Board of Directors

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms. Phillips is the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding se

      12/19/24 9:01:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Appoints Executive Vice President, Strategy and Equity Capital Markets Reinforcing Its Leadership Structure

      Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. "We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this newly created role. He has been a key and trusted advisor in our strategic endeavors and has worked closely with me and Auna for the last three years, playing an integral part of our journey into Mexico and on becoming a public company,"

      9/3/24 11:30:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care

    $AUNA
    Financials

    Live finance-specific insights

    See more
    • Auna Announces 1Q25 Financial Results

      Adjusted EBITDA increases 1% FXN YoY; Peru supports quarterly results, further validating its integrated business model Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the first quarter ended March 31, 2025 ("first quarter 2025" or "1Q25"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 1Q25 Consolidated Highlights Consolidated Revenue decreased 3% YoY to S/1,042 million, increasing +4% FXN Adjusted EBITDA decreased 8% YoY to S/

      5/20/25 4:15:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces Reporting Dates for First Quarter 2025 Financial Results

      Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2025 financial results. Earnings Release Tuesday, May 20, 2025 Time: After Market Close Conference Call Wednesday, May 21, 2025 Time: 8:00 a.m. ET Quiet Period Monday, April 28 through Tuesday, May 20, 2025 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexic

      4/14/25 8:30:00 AM ET
      $AUNA
      Medical/Nursing Services
      Health Care
    • Auna Announces 4Q24 and FY 2024 Financial Results

      Adjusted EBITDA increases 20.1% FXN in FY 2024 and Net Operating Cash Flows increase 15% YoY Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the fourth quarter ended December 31, 2024 ("fourth quarter 2024" or "4Q24") and full year ended 2024 ("full-year 2024" or "FY24"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 4Q24 Consolidated Highlights Consolidated Revenue increased 4% YoY to S/1,063 million, or +11% FXN Adjusted EBIT

      3/10/25 4:15:00 PM ET
      $AUNA
      Medical/Nursing Services
      Health Care